Trials / Completed
CompletedNCT02334033
Cystatin C and Uncontrolled Hypertension
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 903 (actual)
- Sponsor
- Ankara University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Hypertension is an underdiagnosed and undertreated disease in real-life. Blood pressure and kidney functions are known to be closely related. Increased serum level of Cystatin C, a sensitive biomarker for renal function, seems to predict adverse cardiovascular events. The investigators aimed to evaluate the predictive value of serum Cystatin C for control of hypertension in a community-based study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | other |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2015-01-08
- Last updated
- 2015-01-27
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02334033. Inclusion in this directory is not an endorsement.